Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1

Interventions

Cyclophosphamide 58 Dexamethasone 50 Rituximab 39 Peripheral Blood Stem Cell Transplantation 29 Paclitaxel 29 Lenalidomide 28 fludarabine phosphate 27 Gemcitabine 26 Etoposide 26 Bortezomib 26 Cytarabine 25 Busulfan 24 pembrolizumab 21 Radiotherapy 21 Bevacizumab 21 Carboplatin 20 Mycophenolic Acid 19 Melphalan 19 Cisplatin 19 Filgrastim 18 pomalidomide 17 fludarabine 17 Oxaliplatin 17 Antilymphocyte Serum 17 Cyclosporine 16 Tacrolimus 15 Methotrexate 15 Whole-Body Irradiation 14 Methylprednisolone 13 Bendamustine Hydrochloride 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recurrence × Observation × Clear all

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡